Full Text View
Tabular View
No Study Results Posted
Related Studies
A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease
This study has been completed.
Study NCT00453349   Information provided by Bayer
First Received: March 27, 2007   Last Updated: November 11, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pelvic Inflammatory Disease
More general conditions related to this trial
Adnexal Diseases
Genital Diseases, Female
Infection
Pelvic Infection
Interventions listed in this trial
Avelox (Moxifloxacin, BAY12-8039)
Levofloxacin & Metronidazole
Additional drug interventions recognized in this trial
Metronidazole
Moxifloxacin
Ofloxacin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services